Net profit of Bliss GVS Pharma rose 205.49% to Rs 42.31 crore in the quarter ended September 2023 as against Rs 13.85 crore during the previous quarter ended September 2022. Sales rose 22.88% to Rs 211.88 crore in the quarter ended September 2023 as against Rs 172.43 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales211.88172.43 23 OPM %25.6614.24 - PBDT65.5224.79 164 PBT59.1320.19 193 NP42.3113.85 205 Powered by Capital Market - Live News

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 1 November 2023.Powered by Capital Market - Live News

Net profit of Bliss GVS Pharma declined 42.88% to Rs 14.69 crore in the quarter ended June 2023 as against Rs 25.72 crore during the previous quarter ended June 2022. Sales declined 15.45% to Rs 159.52 crore in the quarter ended June 2023 as against Rs 188.66 crore during the previous quarter ended June 2022. ParticularsQuarter Ended�Jun. 2023Jun. 2022% Var. Sales159.52188.66 -15 OPM %15.1820.59 - PBDT27.8343.75 -36 PBT21.6539.20 -45 NP14.6925.72 -43 Powered by Capital Market - Live News

Bliss GVS Pharma will hold a meeting of the Board of Directors of the Company on 1 August 2023.Powered by Capital Market - Live News

Bliss GVS Pharma announced that the 38th Annual General Meeting (AGM) of the company will be held on 19 July 2023.Powered by Capital Market - Live News